BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

65 related articles for article (PubMed ID: 1666907)

  • 1. CMV-specific polymeric and monomeric IgA antibodies in serum of renal transplant patients.
    Merlino C; Angeretti A; Segoloni GP; Giacchino F; Rossetti M; Negro Ponzi A
    Panminerva Med; 1991; 33(4):173-9. PubMed ID: 1666907
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Specific IgM of cytomegaloviruses and primary infection in kidney transplant patients].
    Devillechabrolle A; Nguyen TT; Luciani J; Frantz P; Huraux JM
    Pathol Biol (Paris); 1987 Oct; 35(8):1123-6. PubMed ID: 2825100
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Complications of infections attributed to cytomegalovirus in a group of 52 kidney transplant patients].
    Galezowski N; Godeaut E; Berche P; Bonissol C; Debure A; Kreis H
    Ann Med Interne (Paris); 1987; 138(5):369-71. PubMed ID: 2823666
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Incidence and prognostic value of cytomegalovirus-specific antibodies of the IgM class in kidney transplant recipients].
    Eichler C; Kaden J; May G
    Z Urol Nephrol; 1990 Aug; 83(8):425-9. PubMed ID: 2173294
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Increased IgM and IgM immune complex-like material in the circulation of renal transplant recipients with primary cytomegalovirus infections.
    Baldwin WM; van Es A; Valentijn RM; van Gemert GW; Daha MR; Vanes LA
    Clin Exp Immunol; 1982 Dec; 50(3):515-24. PubMed ID: 6299633
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Late onset of fatal cytomegalovirus infection after renal transplantation. Primary or reactivation infection?
    Linnemann CC; Dunn CR; First MR; Alvira M; Schiff GM
    Arch Intern Med; 1978 Aug; 138(8):1247-50. PubMed ID: 209756
    [TBL] [Abstract][Full Text] [Related]  

  • 7. IgM antibody detection of ppUL80A and ppUL32 by immunoblotting: an early parameter for recurrent cytomegalovirus infection in renal transplant recipients.
    Kraat YJ; Stals FS; Christiaans MH; Lazzarotto T; Landini MP; Bruggeman CA
    J Med Virol; 1996 Mar; 48(3):289-94. PubMed ID: 8801292
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Primary cytomegalovirus infection in an outpatient setting--laboratory markers and clinical aspects.
    Just-Nübling G; Korn S; Ludwig B; Stephan C; Doerr HW; Preiser W
    Infection; 2003 Oct; 31(5):318-23. PubMed ID: 14556056
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Detection of specific IgA antibodies in serum of kidney transplant patients with recurrent cytomegalovirus infection.
    Sarov I; Siqueira-Linhares M; Chardonnet Y; Levy E; Aymard M; Bosshard S; Nord E; Revillard JP
    Intervirology; 1981; 15(4):228-34. PubMed ID: 6271707
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Improvement of cytomegalovirus avidity testing by adjusting the concentration of CMV-specific IgG in test samples.
    Dangel V; Bäder U; Enders G
    J Clin Virol; 2006 Mar; 35(3):303-9. PubMed ID: 16298547
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Relationship between the symptomatic cytomegalovirus infection and the fluctuation of anti-CMV antibodies in patient after renal transplantation].
    Miyamoto N; Takamura Y
    Rinsho Byori; 1992 Feb; 40(2):189-93. PubMed ID: 1316499
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cytomegalovirus mononucleosis--a report of 70 cases in a community hospital.
    Porath A; Schlaeffer F; Sarov I; Keynan A
    Isr J Med Sci; 1987 Apr; 23(4):268-73. PubMed ID: 3040620
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Salivary immunoglobulins in recipients of bone marrow grafts. III. A longitudinal follow-up of CMV specific antibodies.
    Chaushu G; Chaushu S; Slavin S; Or R; Garfunkel AA; Yefenof E
    Bone Marrow Transplant; 1996 Feb; 17(2):237-41. PubMed ID: 8640173
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Evaluation of a radioimmunoassay for IgM-class antibodies against cytomegalovirus.
    Kangro HO
    Br J Exp Pathol; 1980 Oct; 61(5):512-20. PubMed ID: 6255978
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Value of the detection of serum anti-cytomegalovirus antibodies applied to the diagnosis of recent infection].
    Harzic M; Mazeron MC; Bertrand C
    Ann Med Interne (Paris); 1987; 138(5):331-3. PubMed ID: 2823656
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Cytomegalovirus IgM amd IgG antibodies in the sera of patients with acute and chronic upper respiratory infections].
    Cengiz AT; Ataoğlu H; Kiyan M; Kiliç H
    Mikrobiyol Bul; 1990 Oct; 24(4):307-13. PubMed ID: 1962842
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Immunoglobulin levels and specific viral antibodies in relation to smooth-muscle antibodies in cytomegalovirus infection.
    Andersen P; Andersen HK
    J Clin Lab Immunol; 1978 Nov; 1(3):233-6. PubMed ID: 228039
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Primary cytomegalovirus infection in patients with Guillain-Barré syndrome.
    Steininger C; Seiser A; Gueler N; Puchhammer-Stöckl E; Aberle SW; Stanek G; Popow-Kraupp T
    J Neuroimmunol; 2007 Feb; 183(1-2):214-9. PubMed ID: 17184845
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Use of the ISAGA method in detection of specific IgM, IgA, IgE antibodies in acquired and congenital toxoplasmosis].
    Paul M
    Wiad Parazytol; 1997; 43(1):39-51. PubMed ID: 9289926
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparison of serology assays and polymerase chain reaction for the monitoring of active cytomegalovirus infection in renal transplant recipients.
    Naumnik B; Małyszko J; Chyczewski L; Kovalchuk O; Małyszko J; Myśliwiec M
    Transplant Proc; 2007 Nov; 39(9):2748-50. PubMed ID: 18021976
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.